SCHEMBL876507

SCHEMBL876507

CC(C)n1cc(-c2ccc([N+](=O)[O-])cc2)cc1C(=O)NC1CC1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.46
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 3/20 0.41
HPGD P15428 1/20 0.41
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
LRRK2 Q5S007 3/20 0.40
EPHX1 P07099 2/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP7 P09237 1/20 0.40
MMP9 P14780 1/20 0.40
MMP13 P45452 1/20 0.40
F10 P00742 1/20 0.39
DRD4 P21917 1/20 0.39
KHK P50053 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL876773 0.83 LRRK2 (0.42) KMT2ALRRK2
SCHEMBL877737 0.80 MMP2 (0.46) MAPTKMT2AALDH1A1MMP1MMP2
SCHEMBL873743 0.80 PHGDH (0.48) MAPTKMT2AALDH1A1HPGDHSP90AA1
SCHEMBL882660 0.80 SLC6A3 (0.45) MAPTKMT2AALDH1A1HPGDMMP1
SCHEMBL882712 0.70 HDAC6 (0.47)
SCHEMBL21961348 0.70 BRD4 (0.46) ALDH1A1
SCHEMBL30583813 0.70 NPC1 (0.57) MAPTKMT2AALDH1A1EPHX1MMP2
SCHEMBL30583812 0.70 NPC1 (0.57) MAPTKMT2AALDH1A1EPHX1MMP2
SCHEMBL28975685 0.70 NPC1 (0.57) MAPTKMT2AALDH1A1EPHX1MMP2
SCHEMBL874709 0.69 CA12 (0.43) MAPTKMT2AALDH1A1DRD4KHK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012038905-A1 THIENOPYRIDINE NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-03-29 WO disclosed
WO-2012038905-A1 THIENOPYRIDINE NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-03-29 WO disclosed